BioKier
Early-stage pharmaceutical company that develops drugs for diabetes and related disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
€545—818k (Dealroom.co estimates Jan 2015.)
Chapel Hill North Carolina (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $200k | Seed | |
| N/A | $340k | Debt | |
$1.7m | Seed | ||
| N/A | $230k | Angel | |
| N/A | $150k | Debt | |
| N/A | $150k | Seed | |
| Total Funding | €2.1m | ||
Recent News about BioKier
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.